No Data
No Data
RBC Capital Markets Change Price Targets for Certain North American Precious Metals Equities
Stock Selloff Slashes Needed-market Cap for New Russell 2000 Additions: Stephens
Citigroup Maintains Buy on 10x Genomics, Lowers Price Target to $15
10x Genomics Analyst Ratings
Citi Maintains 10x Genomics(TXG.US) With Buy Rating, Cuts Target Price to $15
Express News | 10X Genomics: Co's Litigation Against Parse's Gene Expression Products Remains Ongoing